Los Angeles Capital Management LLC Stoke Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 103,005 shares of STOK stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,005
Previous 66,765
54.28%
Holding current value
$1.14 Million
Previous $901,000
40.4%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STOK
# of Institutions
124Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust8.91MShares$98.5 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$59.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$57.4 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$52.1 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$51.5 Million0.91% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $436M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...